$1.240
-0.029 (-2.37%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de APVO por análisis de gráficos similares
Alphio's APVO stock price prediction model matches the current Aptevo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.25 (+0.92%). The 1-week path is $1.25 (+1.10%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aptevo Therapeutics Inc?
Aptevo Therapeutics is not a good buy right now due to its extremely low RSI of 19.049, indicating oversold conditions, and a staggering year-to-date change of -86.80%. The stock has significant financial challenges, including a reported EPS of -40.11, which is far below expectations. The main risk is its forward P/E of 3.8895, which suggests that while the stock may be undervalued, the company is struggling to generate revenue, as evidenced by total revenue of $0.00 for multiple quarters. The lack of positive cash flow and ongoing losses indicate that investors should be cautious before considering a purchase.
APVO cerró en $1.24 el Friday, tras bajar -2.37%
Aptevo Therapeutics Inc (APVO) last closed at $1.2399, losing -2.37%. These facts feed the 1-day and 1-week APVO price prediction above.
Consenso de analistas
Aptevo Therapeutics Inc (APVO): 1 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Aptevo Therapeutics Inc (APVO) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de APVO, ordenadas por similitud.
Análisis de estacionalidad de APVO
Historically the probability of a positive November return for APVO is 0.00%. January offers the highest probability of a positive month at 16.39%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de APVO
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $2.45 | $2.90 | $2.93 | +133.91% |
| Dec 2026 | $2.54 | $2.81 | $3.29 | +126.55% |
En 2026, se proyecta que Aptevo Therapeutics Inc (APVO) oscile entre $2.45 y $3.29.
Previsión mensual de Aptevo Therapeutics Inc para 2026
En Nov de 2026, se proyecta que Aptevo Therapeutics Inc promedie $2.90, con un mínimo de $2.45 y un máximo de $2.93.
En Dec de 2026, se proyecta que Aptevo Therapeutics Inc promedie $2.81, con un mínimo de $2.54 y un máximo de $3.29.
Artículos relacionados
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.